Biogen vet Adam Koppel is raising cash for a new life sciences fund at Bain Capital
Following a two-year stint as chief strategy officer for Biogen, Adam Koppel took a new job last June helming Bain Capital’s investments in biotech and …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
